Demissie Seifu, Riekert Kristin A, Eakin Michelle N, Bilderback Andrew, Diette Gregory B, Okelo Sande O
Pediatr Allergy Immunol Pulmonol. 2012 Mar;25(1):17-23. doi: 10.1089/ped.2011.0107.
According to National Institutes of Health (NIH) guidelines, asthma control and severity are unique constructs. Little is known about how asthma control and severity are distinguished by pediatricians and if they influence treatment recommendations. METHODS: We conducted a random-sample survey of 500 pediatricians using patient vignettes with different asthma status indicators (recent hospitalization, parental report of bother from asthma, frequent symptoms, parental report of worsening asthma, and wheeze during physical exam) and a visual analog scale (VAS) to rate control and severity. Regression models assessed the independent effects of these indicators on asthma control and severity ratings, and the effects of these ratings on treatment recommendations. RESULTS: A total of 270 respondents provided usable data. Compared to patients with well-controlled asthma: (1) medication intensity influenced only severity ratings; (2) frequent symptoms and recent hospitalization influenced control and severity ratings; (3) wheeze and bother influenced control ratings only (p<0.001 for all comparisons); (4) a report of worse asthma did not significantly affect any ratings (p>0.2). Poorer VAS control ratings were associated with recommendations to step-up treatment (odds ratio [OR] 2.61, 95% confidence interval [CI], 2.2-3.1, p<0.001), but more severe VAS ratings were not (OR 1.02, 95% CI, 0.9-1.2, p=0.8). Recommendations to step-down treatment were associated with poorer VAS control ratings (OR 0.70, 95% CI, 0.6-0.8, p<0.001) and more severe VAS ratings (OR 0.82, 95% CI, 0.7-0.9, p<0.001). CONCLUSIONS: Pediatricians who step-up asthma treatment base their assessments on asthma control, while assessments of both control and severity factor into their decision to step-down asthma therapy.
根据美国国立卫生研究院(NIH)的指南,哮喘控制和严重程度是不同的概念。关于儿科医生如何区分哮喘控制和严重程度,以及它们是否会影响治疗建议,目前知之甚少。
我们对500名儿科医生进行了随机抽样调查,使用具有不同哮喘状态指标(近期住院、家长报告的哮喘困扰、频繁症状、家长报告的哮喘恶化以及体检时的喘息)的患者 vignettes 和视觉模拟量表(VAS)来评估控制和严重程度。回归模型评估了这些指标对哮喘控制和严重程度评分的独立影响,以及这些评分对治疗建议的影响。
共有270名受访者提供了可用数据。与哮喘控制良好的患者相比:(1)用药强度仅影响严重程度评分;(2)频繁症状和近期住院影响控制和严重程度评分;(3)喘息和困扰仅影响控制评分(所有比较 p<0.001);(4)哮喘恶化报告对任何评分均无显著影响(p>0.2)。较差的VAS控制评分与加强治疗的建议相关(优势比[OR] 2.61,95%置信区间[CI],2.2 - 3.1,p<0.001),但更严重的VAS评分则不然(OR 1.02,95% CI,0.9 - 1.2,p = 0.8)。降级治疗的建议与较差的VAS控制评分(OR 0.70,95% CI,0.6 - 0.8,p<0.001)和更严重的VAS评分(OR 0.82,95% CI,0.7 - 0.9,p<0.001)相关。
加强哮喘治疗的儿科医生基于哮喘控制进行评估,而在决定降低哮喘治疗强度时,会同时考虑控制和严重程度因素。